Skip to main content
. 2018 Jul 30;8(7):e022291. doi: 10.1136/bmjopen-2018-022291

Figure 3.

Figure 3

Determinants of the cost of attacks. Coefficients (95% CI) from cost model. pdC1-INH, plasma derived C1-inhibitor.